生体模倣ペプチドのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Biomimetic Peptide Market Insights, Forecast to 2028

• レポートコード：QY2207E00512 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の生体模倣ペプチドの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に生体模倣ペプチドの世界市場のxxx％を占める「Rejuline」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「化粧品」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の生体模倣ペプチドの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの生体模倣ペプチド市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの生体模倣ペプチド市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 生体模倣ペプチドのグローバル主要メーカーには、Lucas Meyer、Koninklijke、DSM、Caregen、Swedish Biomimetics 3000、Pharmannなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 生体模倣ペプチド市場は、種類と用途によって区分されます。世界の生体模倣ペプチド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 Rejuline、Boostrin、CG-EGP3、CG-TGP2、その他 【用途別セグメント】 化粧品、医薬品、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 生体模倣ペプチド製品概要 - 種類別市場（Rejuline、Boostrin、CG-EGP3、CG-TGP2、その他） - 用途別市場（化粧品、医薬品、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の生体模倣ペプチド販売量予測2017-2028 - 世界の生体模倣ペプチド売上予測2017-2028 - 生体模倣ペプチドの地域別販売量 - 生体模倣ペプチドの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別生体模倣ペプチド販売量 - 主要メーカー別生体模倣ペプチド売上 - 主要メーカー別生体模倣ペプチド価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（Rejuline、Boostrin、CG-EGP3、CG-TGP2、その他） - 生体模倣ペプチドの種類別販売量 - 生体模倣ペプチドの種類別売上 - 生体模倣ペプチドの種類別価格 ・用途別市場規模（化粧品、医薬品、その他） - 生体模倣ペプチドの用途別販売量 - 生体模倣ペプチドの用途別売上 - 生体模倣ペプチドの用途別価格 ・北米市場 - 北米の生体模倣ペプチド市場規模（種類別、用途別） - 主要国別の生体模倣ペプチド市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの生体模倣ペプチド市場規模（種類別、用途別） - 主要国別の生体模倣ペプチド市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の生体模倣ペプチド市場規模（種類別、用途別） - 主要国別の生体模倣ペプチド市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の生体模倣ペプチド市場規模（種類別、用途別） - 主要国別の生体模倣ペプチド市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの生体模倣ペプチド市場規模（種類別、用途別） - 主要国別の生体模倣ペプチド市場規模（トルコ、サウジアラビア） ・企業情報 Lucas Meyer、Koninklijke、DSM、Caregen、Swedish Biomimetics 3000、Pharmann ・産業チェーン及び販売チャネル分析 - 生体模倣ペプチドの産業チェーン分析 - 生体模倣ペプチドの原材料 - 生体模倣ペプチドの生産プロセス - 生体模倣ペプチドの販売及びマーケティング - 生体模倣ペプチドの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 生体模倣ペプチドの産業動向 - 生体模倣ペプチドのマーケットドライバー - 生体模倣ペプチドの課題 - 生体模倣ペプチドの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Biomimetic Peptide Market
Due to the COVID-19 pandemic, the global Biomimetic Peptide market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Rejuline accounting for % of the Biomimetic Peptide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cosmetics segment is altered to an % CAGR throughout this forecast period.
China Biomimetic Peptide market size is valued at US$ million in 2021, while the US and Europe Biomimetic Peptide are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Biomimetic Peptide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Biomimetic Peptide include Lucas Meyer, Koninklijke, DSM, Caregen, Swedish Biomimetics 3000 and Pharmann, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Biomimetic Peptide capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Biomimetic Peptide by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Biomimetic Peptide Scope and Segment
Biomimetic Peptide market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Biomimetic Peptide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Rejuline
Boostrin
CG-EGP3
CG-TGP2
Others
Segment by Application
Cosmetics
Pharmaceuticals
Others
By Company
Lucas Meyer
Koninklijke
DSM
Caregen
Swedish Biomimetics 3000
Pharmann
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Biomimetic Peptide Product Introduction
1.2 Market by Type
1.2.1 Global Biomimetic Peptide Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Rejuline
1.2.3 Boostrin
1.2.4 CG-EGP3
1.2.5 CG-TGP2
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biomimetic Peptide Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Cosmetics
1.3.3 Pharmaceuticals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Biomimetic Peptide Production
2.1 Global Biomimetic Peptide Production Capacity (2017-2028)
2.2 Global Biomimetic Peptide Production by Region: 2017 VS 2021 VS 2028
2.3 Global Biomimetic Peptide Production by Region
2.3.1 Global Biomimetic Peptide Historic Production by Region (2017-2022)
2.3.2 Global Biomimetic Peptide Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Biomimetic Peptide Sales in Volume & Value Estimates and Forecasts
3.1 Global Biomimetic Peptide Sales Estimates and Forecasts 2017-2028
3.2 Global Biomimetic Peptide Revenue Estimates and Forecasts 2017-2028
3.3 Global Biomimetic Peptide Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Biomimetic Peptide Sales by Region
3.4.1 Global Biomimetic Peptide Sales by Region (2017-2022)
3.4.2 Global Sales Biomimetic Peptide by Region (2023-2028)
3.5 Global Biomimetic Peptide Revenue by Region
3.5.1 Global Biomimetic Peptide Revenue by Region (2017-2022)
3.5.2 Global Biomimetic Peptide Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Biomimetic Peptide Production Capacity by Manufacturers
4.2 Global Biomimetic Peptide Sales by Manufacturers
4.2.1 Global Biomimetic Peptide Sales by Manufacturers (2017-2022)
4.2.2 Global Biomimetic Peptide Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Biomimetic Peptide in 2021
4.3 Global Biomimetic Peptide Revenue by Manufacturers
4.3.1 Global Biomimetic Peptide Revenue by Manufacturers (2017-2022)
4.3.2 Global Biomimetic Peptide Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Biomimetic Peptide Revenue in 2021
4.4 Global Biomimetic Peptide Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Biomimetic Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Biomimetic Peptide Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Biomimetic Peptide Sales by Type
5.1.1 Global Biomimetic Peptide Historical Sales by Type (2017-2022)
5.1.2 Global Biomimetic Peptide Forecasted Sales by Type (2023-2028)
5.1.3 Global Biomimetic Peptide Sales Market Share by Type (2017-2028)
5.2 Global Biomimetic Peptide Revenue by Type
5.2.1 Global Biomimetic Peptide Historical Revenue by Type (2017-2022)
5.2.2 Global Biomimetic Peptide Forecasted Revenue by Type (2023-2028)
5.2.3 Global Biomimetic Peptide Revenue Market Share by Type (2017-2028)
5.3 Global Biomimetic Peptide Price by Type
5.3.1 Global Biomimetic Peptide Price by Type (2017-2022)
5.3.2 Global Biomimetic Peptide Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Biomimetic Peptide Sales by Application
6.1.1 Global Biomimetic Peptide Historical Sales by Application (2017-2022)
6.1.2 Global Biomimetic Peptide Forecasted Sales by Application (2023-2028)
6.1.3 Global Biomimetic Peptide Sales Market Share by Application (2017-2028)
6.2 Global Biomimetic Peptide Revenue by Application
6.2.1 Global Biomimetic Peptide Historical Revenue by Application (2017-2022)
6.2.2 Global Biomimetic Peptide Forecasted Revenue by Application (2023-2028)
6.2.3 Global Biomimetic Peptide Revenue Market Share by Application (2017-2028)
6.3 Global Biomimetic Peptide Price by Application
6.3.1 Global Biomimetic Peptide Price by Application (2017-2022)
6.3.2 Global Biomimetic Peptide Price Forecast by Application (2023-2028)
7 North America
7.1 North America Biomimetic Peptide Market Size by Type
7.1.1 North America Biomimetic Peptide Sales by Type (2017-2028)
7.1.2 North America Biomimetic Peptide Revenue by Type (2017-2028)
7.2 North America Biomimetic Peptide Market Size by Application
7.2.1 North America Biomimetic Peptide Sales by Application (2017-2028)
7.2.2 North America Biomimetic Peptide Revenue by Application (2017-2028)
7.3 North America Biomimetic Peptide Sales by Country
7.3.1 North America Biomimetic Peptide Sales by Country (2017-2028)
7.3.2 North America Biomimetic Peptide Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Biomimetic Peptide Market Size by Type
8.1.1 Europe Biomimetic Peptide Sales by Type (2017-2028)
8.1.2 Europe Biomimetic Peptide Revenue by Type (2017-2028)
8.2 Europe Biomimetic Peptide Market Size by Application
8.2.1 Europe Biomimetic Peptide Sales by Application (2017-2028)
8.2.2 Europe Biomimetic Peptide Revenue by Application (2017-2028)
8.3 Europe Biomimetic Peptide Sales by Country
8.3.1 Europe Biomimetic Peptide Sales by Country (2017-2028)
8.3.2 Europe Biomimetic Peptide Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Biomimetic Peptide Market Size by Type
9.1.1 Asia Pacific Biomimetic Peptide Sales by Type (2017-2028)
9.1.2 Asia Pacific Biomimetic Peptide Revenue by Type (2017-2028)
9.2 Asia Pacific Biomimetic Peptide Market Size by Application
9.2.1 Asia Pacific Biomimetic Peptide Sales by Application (2017-2028)
9.2.2 Asia Pacific Biomimetic Peptide Revenue by Application (2017-2028)
9.3 Asia Pacific Biomimetic Peptide Sales by Region
9.3.1 Asia Pacific Biomimetic Peptide Sales by Region (2017-2028)
9.3.2 Asia Pacific Biomimetic Peptide Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Biomimetic Peptide Market Size by Type
10.1.1 Latin America Biomimetic Peptide Sales by Type (2017-2028)
10.1.2 Latin America Biomimetic Peptide Revenue by Type (2017-2028)
10.2 Latin America Biomimetic Peptide Market Size by Application
10.2.1 Latin America Biomimetic Peptide Sales by Application (2017-2028)
10.2.2 Latin America Biomimetic Peptide Revenue by Application (2017-2028)
10.3 Latin America Biomimetic Peptide Sales by Country
10.3.1 Latin America Biomimetic Peptide Sales by Country (2017-2028)
10.3.2 Latin America Biomimetic Peptide Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Biomimetic Peptide Market Size by Type
11.1.1 Middle East and Africa Biomimetic Peptide Sales by Type (2017-2028)
11.1.2 Middle East and Africa Biomimetic Peptide Revenue by Type (2017-2028)
11.2 Middle East and Africa Biomimetic Peptide Market Size by Application
11.2.1 Middle East and Africa Biomimetic Peptide Sales by Application (2017-2028)
11.2.2 Middle East and Africa Biomimetic Peptide Revenue by Application (2017-2028)
11.3 Middle East and Africa Biomimetic Peptide Sales by Country
11.3.1 Middle East and Africa Biomimetic Peptide Sales by Country (2017-2028)
11.3.2 Middle East and Africa Biomimetic Peptide Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Lucas Meyer
12.1.1 Lucas Meyer Corporation Information
12.1.2 Lucas Meyer Overview
12.1.3 Lucas Meyer Biomimetic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Lucas Meyer Biomimetic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Lucas Meyer Recent Developments
12.2 Koninklijke
12.2.1 Koninklijke Corporation Information
12.2.2 Koninklijke Overview
12.2.3 Koninklijke Biomimetic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Koninklijke Biomimetic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Koninklijke Recent Developments
12.3 DSM
12.3.1 DSM Corporation Information
12.3.2 DSM Overview
12.3.3 DSM Biomimetic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 DSM Biomimetic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 DSM Recent Developments
12.4 Caregen
12.4.1 Caregen Corporation Information
12.4.2 Caregen Overview
12.4.3 Caregen Biomimetic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Caregen Biomimetic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Caregen Recent Developments
12.5 Swedish Biomimetics 3000
12.5.1 Swedish Biomimetics 3000 Corporation Information
12.5.2 Swedish Biomimetics 3000 Overview
12.5.3 Swedish Biomimetics 3000 Biomimetic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Swedish Biomimetics 3000 Biomimetic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Swedish Biomimetics 3000 Recent Developments
12.6 Pharmann
12.6.1 Pharmann Corporation Information
12.6.2 Pharmann Overview
12.6.3 Pharmann Biomimetic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Pharmann Biomimetic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Pharmann Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Biomimetic Peptide Industry Chain Analysis
13.2 Biomimetic Peptide Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Biomimetic Peptide Production Mode & Process
13.4 Biomimetic Peptide Sales and Marketing
13.4.1 Biomimetic Peptide Sales Channels
13.4.2 Biomimetic Peptide Distributors
13.5 Biomimetic Peptide Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Biomimetic Peptide Industry Trends
14.2 Biomimetic Peptide Market Drivers
14.3 Biomimetic Peptide Market Challenges
14.4 Biomimetic Peptide Market Restraints
15 Key Finding in The Global Biomimetic Peptide Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Biomimetic Peptide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Rejuline
Table 3. Major Manufacturers of Boostrin
Table 4. Major Manufacturers of CG-EGP3
Table 5. Major Manufacturers of CG-TGP2
Table 6. Major Manufacturers of Others
Table 7. Global Biomimetic Peptide Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 8. Global Biomimetic Peptide Production by Region: 2017 VS 2021 VS 2028 (Kg)
Table 9. Global Biomimetic Peptide Production by Region (2017-2022) & (Kg)
Table 10. Global Biomimetic Peptide Production Market Share by Region (2017-2022)
Table 11. Global Biomimetic Peptide Production by Region (2023-2028) & (Kg)
Table 12. Global Biomimetic Peptide Production Market Share by Region (2023-2028)
Table 13. Global Biomimetic Peptide Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 14. Global Biomimetic Peptide Sales by Region (2017-2022) & (Kg)
Table 15. Global Biomimetic Peptide Sales Market Share by Region (2017-2022)
Table 16. Global Biomimetic Peptide Sales by Region (2023-2028) & (Kg)
Table 17. Global Biomimetic Peptide Sales Market Share by Region (2023-2028)
Table 18. Global Biomimetic Peptide Revenue by Region (2017-2022) & (US$ Million)
Table 19. Global Biomimetic Peptide Revenue Market Share by Region (2017-2022)
Table 20. Global Biomimetic Peptide Revenue by Region (2023-2028) & (US$ Million)
Table 21. Global Biomimetic Peptide Revenue Market Share by Region (2023-2028)
Table 22. Global Biomimetic Peptide Production Capacity by Manufacturers (2017-2022) & (Kg)
Table 23. Global Biomimetic Peptide Capacity Market Share by Manufacturers (2017-2022)
Table 24. Global Biomimetic Peptide Sales by Manufacturers (2017-2022) & (Kg)
Table 25. Global Biomimetic Peptide Sales Market Share by Manufacturers (2017-2022)
Table 26. Global Biomimetic Peptide Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 27. Global Biomimetic Peptide Revenue Share by Manufacturers (2017-2022)
Table 28. Biomimetic Peptide Price by Manufacturers 2017-2022 (US$/Kg)
Table 29. Global Biomimetic Peptide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Biomimetic Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomimetic Peptide as of 2021)
Table 31. Biomimetic Peptide Manufacturing Base Distribution and Headquarters
Table 32. Manufacturers Biomimetic Peptide Product Offered
Table 33. Date of Manufacturers Enter into Biomimetic Peptide Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Biomimetic Peptide Sales by Type (2017-2022) & (Kg)
Table 36. Global Biomimetic Peptide Sales by Type (2023-2028) & (Kg)
Table 37. Global Biomimetic Peptide Sales Share by Type (2017-2022)
Table 38. Global Biomimetic Peptide Sales Share by Type (2023-2028)
Table 39. Global Biomimetic Peptide Revenue by Type (2017-2022) & (US$ Million)
Table 40. Global Biomimetic Peptide Revenue by Type (2023-2028) & (US$ Million)
Table 41. Global Biomimetic Peptide Revenue Share by Type (2017-2022)
Table 42. Global Biomimetic Peptide Revenue Share by Type (2023-2028)
Table 43. Biomimetic Peptide Price by Type (2017-2022) & (US$/Kg)
Table 44. Global Biomimetic Peptide Price Forecast by Type (2023-2028) & (US$/Kg)
Table 45. Global Biomimetic Peptide Sales by Application (2017-2022) & (Kg)
Table 46. Global Biomimetic Peptide Sales by Application (2023-2028) & (Kg)
Table 47. Global Biomimetic Peptide Sales Share by Application (2017-2022)
Table 48. Global Biomimetic Peptide Sales Share by Application (2023-2028)
Table 49. Global Biomimetic Peptide Revenue by Application (2017-2022) & (US$ Million)
Table 50. Global Biomimetic Peptide Revenue by Application (2023-2028) & (US$ Million)
Table 51. Global Biomimetic Peptide Revenue Share by Application (2017-2022)
Table 52. Global Biomimetic Peptide Revenue Share by Application (2023-2028)
Table 53. Biomimetic Peptide Price by Application (2017-2022) & (US$/Kg)
Table 54. Global Biomimetic Peptide Price Forecast by Application (2023-2028) & (US$/Kg)
Table 55. North America Biomimetic Peptide Sales by Type (2017-2022) & (Kg)
Table 56. North America Biomimetic Peptide Sales by Type (2023-2028) & (Kg)
Table 57. North America Biomimetic Peptide Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Biomimetic Peptide Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Biomimetic Peptide Sales by Application (2017-2022) & (Kg)
Table 60. North America Biomimetic Peptide Sales by Application (2023-2028) & (Kg)
Table 61. North America Biomimetic Peptide Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Biomimetic Peptide Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Biomimetic Peptide Sales by Country (2017-2022) & (Kg)
Table 64. North America Biomimetic Peptide Sales by Country (2023-2028) & (Kg)
Table 65. North America Biomimetic Peptide Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Biomimetic Peptide Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Biomimetic Peptide Sales by Type (2017-2022) & (Kg)
Table 68. Europe Biomimetic Peptide Sales by Type (2023-2028) & (Kg)
Table 69. Europe Biomimetic Peptide Revenue by Type (2017-2022) & (US$ Million)
Table 70. Europe Biomimetic Peptide Revenue by Type (2023-2028) & (US$ Million)
Table 71. Europe Biomimetic Peptide Sales by Application (2017-2022) & (Kg)
Table 72. Europe Biomimetic Peptide Sales by Application (2023-2028) & (Kg)
Table 73. Europe Biomimetic Peptide Revenue by Application (2017-2022) & (US$ Million)
Table 74. Europe Biomimetic Peptide Revenue by Application (2023-2028) & (US$ Million)
Table 75. Europe Biomimetic Peptide Sales by Country (2017-2022) & (Kg)
Table 76. Europe Biomimetic Peptide Sales by Country (2023-2028) & (Kg)
Table 77. Europe Biomimetic Peptide Revenue by Country (2017-2022) & (US$ Million)
Table 78. Europe Biomimetic Peptide Revenue by Country (2023-2028) & (US$ Million)
Table 79. Asia Pacific Biomimetic Peptide Sales by Type (2017-2022) & (Kg)
Table 80. Asia Pacific Biomimetic Peptide Sales by Type (2023-2028) & (Kg)
Table 81. Asia Pacific Biomimetic Peptide Revenue by Type (2017-2022) & (US$ Million)
Table 82. Asia Pacific Biomimetic Peptide Revenue by Type (2023-2028) & (US$ Million)
Table 83. Asia Pacific Biomimetic Peptide Sales by Application (2017-2022) & (Kg)
Table 84. Asia Pacific Biomimetic Peptide Sales by Application (2023-2028) & (Kg)
Table 85. Asia Pacific Biomimetic Peptide Revenue by Application (2017-2022) & (US$ Million)
Table 86. Asia Pacific Biomimetic Peptide Revenue by Application (2023-2028) & (US$ Million)
Table 87. Asia Pacific Biomimetic Peptide Sales by Region (2017-2022) & (Kg)
Table 88. Asia Pacific Biomimetic Peptide Sales by Region (2023-2028) & (Kg)
Table 89. Asia Pacific Biomimetic Peptide Revenue by Region (2017-2022) & (US$ Million)
Table 90. Asia Pacific Biomimetic Peptide Revenue by Region (2023-2028) & (US$ Million)
Table 91. Latin America Biomimetic Peptide Sales by Type (2017-2022) & (Kg)
Table 92. Latin America Biomimetic Peptide Sales by Type (2023-2028) & (Kg)
Table 93. Latin America Biomimetic Peptide Revenue by Type (2017-2022) & (US$ Million)
Table 94. Latin America Biomimetic Peptide Revenue by Type (2023-2028) & (US$ Million)
Table 95. Latin America Biomimetic Peptide Sales by Application (2017-2022) & (Kg)
Table 96. Latin America Biomimetic Peptide Sales by Application (2023-2028) & (Kg)
Table 97. Latin America Biomimetic Peptide Revenue by Application (2017-2022) & (US$ Million)
Table 98. Latin America Biomimetic Peptide Revenue by Application (2023-2028) & (US$ Million)
Table 99. Latin America Biomimetic Peptide Sales by Country (2017-2022) & (Kg)
Table 100. Latin America Biomimetic Peptide Sales by Country (2023-2028) & (Kg)
Table 101. Latin America Biomimetic Peptide Revenue by Country (2017-2022) & (US$ Million)
Table 102. Latin America Biomimetic Peptide Revenue by Country (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Biomimetic Peptide Sales by Type (2017-2022) & (Kg)
Table 104. Middle East and Africa Biomimetic Peptide Sales by Type (2023-2028) & (Kg)
Table 105. Middle East and Africa Biomimetic Peptide Revenue by Type (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Biomimetic Peptide Revenue by Type (2023-2028) & (US$ Million)
Table 107. Middle East and Africa Biomimetic Peptide Sales by Application (2017-2022) & (Kg)
Table 108. Middle East and Africa Biomimetic Peptide Sales by Application (2023-2028) & (Kg)
Table 109. Middle East and Africa Biomimetic Peptide Revenue by Application (2017-2022) & (US$ Million)
Table 110. Middle East and Africa Biomimetic Peptide Revenue by Application (2023-2028) & (US$ Million)
Table 111. Middle East and Africa Biomimetic Peptide Sales by Country (2017-2022) & (Kg)
Table 112. Middle East and Africa Biomimetic Peptide Sales by Country (2023-2028) & (Kg)
Table 113. Middle East and Africa Biomimetic Peptide Revenue by Country (2017-2022) & (US$ Million)
Table 114. Middle East and Africa Biomimetic Peptide Revenue by Country (2023-2028) & (US$ Million)
Table 115. Lucas Meyer Corporation Information
Table 116. Lucas Meyer Description and Major Businesses
Table 117. Lucas Meyer Biomimetic Peptide Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 118. Lucas Meyer Biomimetic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Lucas Meyer Recent Development
Table 120. Koninklijke Corporation Information
Table 121. Koninklijke Description and Major Businesses
Table 122. Koninklijke Biomimetic Peptide Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 123. Koninklijke Biomimetic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Koninklijke Recent Development
Table 125. DSM Corporation Information
Table 126. DSM Description and Major Businesses
Table 127. DSM Biomimetic Peptide Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 128. DSM Biomimetic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. DSM Recent Development
Table 130. Caregen Corporation Information
Table 131. Caregen Description and Major Businesses
Table 132. Caregen Biomimetic Peptide Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 133. Caregen Biomimetic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Caregen Recent Development
Table 135. Swedish Biomimetics 3000 Corporation Information
Table 136. Swedish Biomimetics 3000 Description and Major Businesses
Table 137. Swedish Biomimetics 3000 Biomimetic Peptide Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 138. Swedish Biomimetics 3000 Biomimetic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Swedish Biomimetics 3000 Recent Development
Table 140. Pharmann Corporation Information
Table 141. Pharmann Description and Major Businesses
Table 142. Pharmann Biomimetic Peptide Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 143. Pharmann Biomimetic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Pharmann Recent Development
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Biomimetic Peptide Distributors List
Table 148. Biomimetic Peptide Customers List
Table 149. Biomimetic Peptide Market Trends
Table 150. Biomimetic Peptide Market Drivers
Table 151. Biomimetic Peptide Market Challenges
Table 152. Biomimetic Peptide Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Biomimetic Peptide Product Picture
Figure 2. Global Biomimetic Peptide Market Share by Type in 2021 & 2028
Figure 3. Rejuline Product Picture
Figure 4. Boostrin Product Picture
Figure 5. CG-EGP3 Product Picture
Figure 6. CG-TGP2 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Biomimetic Peptide Market Share by Application in 2021 & 2028
Figure 9. Cosmetics
Figure 10. Pharmaceuticals
Figure 11. Others
Figure 12. Biomimetic Peptide Report Years Considered
Figure 13. Global Biomimetic Peptide Capacity, Production and Utilization (2017-2028) & (Kg)
Figure 14. Global Biomimetic Peptide Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Biomimetic Peptide Production Market Share by Region (2017-2022)
Figure 16. Global Biomimetic Peptide Production Market Share by Region (2023-2028)
Figure 17. Biomimetic Peptide Production Growth Rate in North America (2017-2028) & (Kg)
Figure 18. Biomimetic Peptide Production Growth Rate in Europe (2017-2028) & (Kg)
Figure 19. Biomimetic Peptide Production Growth Rate in China (2017-2028) & (Kg)
Figure 20. Biomimetic Peptide Production Growth Rate in Japan (2017-2028) & (Kg)
Figure 21. Global Biomimetic Peptide Sales 2017-2028 (Kg)
Figure 22. Global Biomimetic Peptide Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 23. Global Biomimetic Peptide Revenue 2017-2028 (US$ Million)
Figure 24. Global Biomimetic Peptide Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 25. Global Biomimetic Peptide Sales Market Share by Region (2017-2022)
Figure 26. Global Biomimetic Peptide Sales Market Share by Region (2023-2028)
Figure 27. North America Biomimetic Peptide Sales YoY (2017-2028) & (Kg)
Figure 28. North America Biomimetic Peptide Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Europe Biomimetic Peptide Sales YoY (2017-2028) & (Kg)
Figure 30. Europe Biomimetic Peptide Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Biomimetic Peptide Sales YoY (2017-2028) & (Kg)
Figure 32. Asia-Pacific Biomimetic Peptide Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Latin America Biomimetic Peptide Sales YoY (2017-2028) & (Kg)
Figure 34. Latin America Biomimetic Peptide Revenue YoY (2017-2028) & (US$ Million)
Figure 35. Middle East & Africa Biomimetic Peptide Sales YoY (2017-2028) & (Kg)
Figure 36. Middle East & Africa Biomimetic Peptide Revenue YoY (2017-2028) & (US$ Million)
Figure 37. The Biomimetic Peptide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 38. The Top 5 and 10 Largest Manufacturers of Biomimetic Peptide in the World: Market Share by Biomimetic Peptide Revenue in 2021
Figure 39. Biomimetic Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 40. Global Biomimetic Peptide Sales Market Share by Type (2017-2028)
Figure 41. Global Biomimetic Peptide Revenue Market Share by Type (2017-2028)
Figure 42. Global Biomimetic Peptide Sales Market Share by Application (2017-2028)
Figure 43. Global Biomimetic Peptide Revenue Market Share by Application (2017-2028)
Figure 44. North America Biomimetic Peptide Sales Market Share by Type (2017-2028)
Figure 45. North America Biomimetic Peptide Revenue Market Share by Type (2017-2028)
Figure 46. North America Biomimetic Peptide Sales Market Share by Application (2017-2028)
Figure 47. North America Biomimetic Peptide Revenue Market Share by Application (2017-2028)
Figure 48. North America Biomimetic Peptide Sales Share by Country (2017-2028)
Figure 49. North America Biomimetic Peptide Revenue Share by Country (2017-2028)
Figure 50. United States Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 51. Canada Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 52. Europe Biomimetic Peptide Sales Market Share by Type (2017-2028)
Figure 53. Europe Biomimetic Peptide Revenue Market Share by Type (2017-2028)
Figure 54. Europe Biomimetic Peptide Sales Market Share by Application (2017-2028)
Figure 55. Europe Biomimetic Peptide Revenue Market Share by Application (2017-2028)
Figure 56. Europe Biomimetic Peptide Sales Share by Country (2017-2028)
Figure 57. Europe Biomimetic Peptide Revenue Share by Country (2017-2028)
Figure 58. Germany Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 59. France Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 60. U.K. Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 61. Italy Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 62. Russia Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 63. Asia Pacific Biomimetic Peptide Sales Market Share by Type (2017-2028)
Figure 64. Asia Pacific Biomimetic Peptide Revenue Market Share by Type (2017-2028)
Figure 65. Asia Pacific Biomimetic Peptide Sales Market Share by Application (2017-2028)
Figure 66. Asia Pacific Biomimetic Peptide Revenue Market Share by Application (2017-2028)
Figure 67. Asia Pacific Biomimetic Peptide Sales Share by Region (2017-2028)
Figure 68. Asia Pacific Biomimetic Peptide Revenue Share by Region (2017-2028)
Figure 69. China Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 70. Japan Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 71. South Korea Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 72. India Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 73. Australia Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 74. China Taiwan Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 75. Indonesia Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 76. Thailand Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 77. Malaysia Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 78. Latin America Biomimetic Peptide Sales Market Share by Type (2017-2028)
Figure 79. Latin America Biomimetic Peptide Revenue Market Share by Type (2017-2028)
Figure 80. Latin America Biomimetic Peptide Sales Market Share by Application (2017-2028)
Figure 81. Latin America Biomimetic Peptide Revenue Market Share by Application (2017-2028)
Figure 82. Latin America Biomimetic Peptide Sales Share by Country (2017-2028)
Figure 83. Latin America Biomimetic Peptide Revenue Share by Country (2017-2028)
Figure 84. Mexico Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 85. Brazil Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 86. Argentina Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 87. Colombia Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 88. Middle East and Africa Biomimetic Peptide Sales Market Share by Type (2017-2028)
Figure 89. Middle East and Africa Biomimetic Peptide Revenue Market Share by Type (2017-2028)
Figure 90. Middle East and Africa Biomimetic Peptide Sales Market Share by Application (2017-2028)
Figure 91. Middle East and Africa Biomimetic Peptide Revenue Market Share by Application (2017-2028)
Figure 92. Middle East and Africa Biomimetic Peptide Sales Share by Country (2017-2028)
Figure 93. Middle East and Africa Biomimetic Peptide Revenue Share by Country (2017-2028)
Figure 94. Turkey Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 95. Saudi Arabia Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 96. UAE Biomimetic Peptide Revenue (2017-2028) & (US$ Million)
Figure 97. Biomimetic Peptide Value Chain
Figure 98. Biomimetic Peptide Production Process
Figure 99. Channels of Distribution
Figure 100. Distributors Profiles
Figure 101. Bottom-up and Top-down Approaches for This Report
Figure 102. Data Triangulation
Figure 103. Key Executives Interviewed

---